GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (XSWX:VRX) » Definitions » Current Deferred Revenue

Bausch Health (XSWX:VRX) Current Deferred Revenue : CHF0 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Bausch Health Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Bausch Health's current deferred revenue for the quarter that ended in Dec. 2023 was CHF0 Mil.

Bausch Health Current Deferred Revenue Historical Data

The historical data trend for Bausch Health's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Current Deferred Revenue Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bausch Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bausch Health Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Bausch Health's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health (XSWX:VRX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (XSWX:VRX) » Definitions » Current Deferred Revenue
Comparable Companies
XCNQ:GTII TSX:CURA XCNQ:TRUL NEOE:VRNO TSX:CRON TSX:WEED XCNQ:CL TSX:DHT.U NEOE:GLAS.A.U TSX:TSND ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
BHC:USA BVF:Germany BHC:Canada
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Website
https://www.bauschhealth.com
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (XSWX:VRX) Headlines

No Headlines